Personalis to Present at Upcoming Investor Conferences
29 4월 2022 - 5:01AM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that its management team will present
at the following investor conferences:
- Bank of America 2022 Healthcare Conference Presenting on
Wednesday, May 11, 2022 at 6:20 p.m. Eastern Time at the Encore
Hotel in Las Vegas A live audio webcast and replay of the
presentation may be accessed for 90 days on the “Investors” section
of the company’s website at: https://personalis.com/.
- UBS Global Healthcare Conference 2022 Presenting on Tuesday,
May 24, 2022 at 3:30 p.m. Eastern Time at the Lotte New York Palace
Hotel in New York
About Personalis
Personalis, Inc. is a leader in advanced cancer genomics,
enabling the next generation of precision cancer therapies and
diagnostics. The Personalis NeXT Platform® is designed to adapt to
the complex and evolving understanding of cancer, providing its
biopharmaceutical customers and clinicians with information on all
of the approximately 20,000 human genes, together with the immune
system, from a single sample. To enable cancer sequencing,
Personalis' Clinical Laboratory was built with a focus on clinical
accuracy, quality, big data, scale, and efficiency. The laboratory
is GxP-aligned as well as Clinical Laboratory Improvement
Amendments of 1988-certified and College of American
Pathologists-accredited. For more information, visit the Personalis
website and follow Personalis on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220428006149/en/
Investor Relations Contact: Caroline Corner
investors@personalis.com 415-202-5678
Media Contact: Jennifer Temple pr@personalis.com
www.personalis.com 650-752-1300
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024